wakix
bioprojet pharma - pitolisant - narcolepsy - other nervous system drugs - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.1).
wakix 18mg tablets
lincoln medical ltd - pitolisant hydrochloride - tablet - 18mg
wakix 4.5mg tablets
lincoln medical ltd - pitolisant hydrochloride - tablet - 4.5mg
wakix 18 mg
truemed ltd, israel - pitolisant as hydrochloride - film coated tablets - pitolisant as hydrochloride 17.8 mg - pitolisant - wakix is indicated• in adults for the treatment of narcolepsy with or without cataplexy. • to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa) whose eds has not been satisfactorily treated by, or who have not tolerated, osa primary therapy, such as continuous positive airway pressure (cpap).
wakix 4.5 mg
truemed ltd, israel - pitolisant as hydrochloride - film coated tablets - pitolisant as hydrochloride 4.45 mg - pitolisant - wakix is indicated• in adults for the treatment of narcolepsy with or without cataplexy. • to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa) whose eds has not been satisfactorily treated by, or who have not tolerated, osa primary therapy, such as continuous positive airway pressure (cpap).
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - other nervous system drugs - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa)
wakix tablet
endo ventures ltd. - pitolisant hydrochloride - tablet - 5mg - pitolisant hydrochloride 5mg - wakefulness-promoting agents
wakix tablet
endo ventures ltd. - pitolisant hydrochloride - tablet - 20mg - pitolisant hydrochloride 20mg - wakefulness-promoting agents